D.A. Davidson analyst Matt Summerville maintained a Hold rating on Hillenbrand (HI – Research Report) today and set a price target of $33.00.

According to the terms of the deal, Bain has agreed to acquire a 51 percent stake in Milacron for $287 million.

Citi analyst Kyle Menges increased the price target on Timken (NYSE:TKR) shares to $95, up from the previous $85, while reiterating a Buy rating on the stock. The adjustment follows a review of Timken ...

Highlights,Hillenbrand's Q1 revenue of $707 million decreased 9% year-over-year, in line with expectations.,The company is ...

The pharmaceuticals major was boosted by high demand for its key drugs that offset a slight sales drop in China. The company disclosed preliminary results in mid January, but it left out important ...

KeyBanc analyst Jeffrey Hammond reiterated a Buy rating on Hillenbrand (HI – Research Report) today. The company’s shares closed yesterday at ...

An affiliate of Bain Capital will acquire 51 per cent of the injection molding and extrusion machinery maker from current owner Hillenbrand Inc.

Agencies overseeing consumer financial affairs, wealth managers, and commodity traders all seem to be scaling back oversight activity. It's too early to determine the impact of tariffs and other Trump ...

The University of Arizona softball is entering its season with high expectations and a stacked roster. The Cats are ready to ...

Key alts deals unveiled today include Silver Point's $250 million CLO fund close, Bain Capital's stake in manufacturer Milacron, a KKR-backed tech acquisition.

The provider of highly-engineered processing equipment and solutions will sell a 51% stake in the injection molding and extrusion business for $287 million.